Business Context and Reporting Period
This Form 8-K is filed by Landec Corporation (not Lifecore Biomedical, Inc., as noted in the metadata request) on July 31, 2018. The report announces the consolidated financial results for the fourth quarter of fiscal year 2018 and the full fiscal year ended May 27, 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not explicitly detail material changes versus prior periods in the main text. It serves as a notification that the results have been issued via a press release.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information furnished, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation, not Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (the press release) for actual financial figures, as they are absent from the 8-K body text.
- Confirm the fiscal year end date of May 27, 2018 when comparing to other reporting periods.
- Note that the financial data in this report is furnished and not "filed" under Section 18 of the Exchange Act.